Fatigue is difficult to measure, particularly since the symptom does not correlate well with motor or cognitive measures of fatigability [4, 5] . Hence, the patients' report is the only information available to rate severity. Multiple fatigue scales with strong psychometric properties are available [6] , and studies using these measures have shown that fatigue is associated with feelings of loss of control, psychological distress, and pain [7] . MS fatigue clearly differs from the fatigue that healthy adults experience in that it is more severe, disabling, and more likely to keep individuals from meeting their responsibilities [8] . Unfortunately, the biological basis for these differences remains unclear.
In the current issue, the papers by Stanton et al ., [9] and Tellez et al ., [10] provide direct and indirect evidence that alteration in neuroendocrine function and circadian rhythm may mediate fatigue. The paper by Stanton et al ., [9] addresses the important role of sleep in MS. Sixty patients with MS completed sleep diaries over a seven-day period. More than 70% of the patients took day-time naps two or more days a week, and different periods of night-time sleep were characterized by different types of insomnia. Fatigue severity was most strongly associated with the number of days in which patients reported waking up at least twice during the night. Such awakenings were most frequently attributed to bladder problems or pain. In essence, Stanton et al . show that diverse MS symptoms can produce disrupted sleep and poor sleep can lead to increased fatigue.
A relation between sleep and fatigue is supported by prior research. For example, one analysis of mood, degree of neurological impairment, and sleep disturbance showed that each independently contributed to fatigue, but that sleep was the strongest predictor [11] . An association between disrupted sleep and fatigue has also been demonstrated with objective testing. Among MS patients evaluated with actinography, those with more severe fatigue had increased movements during sleep consistent with episodes of arousal and alterations in circadian rhythm [12] .
Tellez et al. [10] report that MS patients with elevated fatigue have low circulating levels of the adrenal neurohormone, dehydroepiandrosterone (DHEA) and its sulphated conjugate, DHEAS. These low levels are present both at baseline and during subsequent time points over a 12-months period. Low DHEA levels have been previously linked to MS [13] , and presumably reflect HPA axis dysfunction. It has been suggested that circulating levels of proinflammatory cytokines associated with MS can result in dysregulation of the HPA axis which causes fatigue [14] . Tellez et al . offer the hypothesis that MS fatigue results from disease-associated changes in neuroimmune and neuroendocrine function. To test this hypothesis, future studies with larger sample sizes are needed. Such studies will have to address variables, such as mood, perceived stress and pain, as well as factors that relate to immune status and circadian rhythm.
Both papers in this issue implicate central nervous system mechanisms (CNS) as being etiologically relevant to fatigue. The contribution of CNS disturbance to fatigue is supported by the moderate correlations between fatigue severity and neuroimaging measures of axonal injury, atrophy, and decreased cerebral glucose utilization [15 Á 17] . Improved definition of the CNS mechanisms underlying fatigue should lead to more effective and targeted interventions. Nonetheless, any proposed fatigue treatment will also need to address the multiple factors which contribute to fatigue, including pain, mood, sleep, coping ability, and degree of psychosocial support.
